Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 12.958.485.937.805.15

What is the latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS is 12.95 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202412.95
Mar20238.48
Mar20225.93
Mar20217.80
Mar20205.15

How is EV/Core EBITDA of GLENMARK PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 12.95
52.71
Mar2023 8.48
43.00
Mar2022 5.93
-23.97
Mar2021 7.8
51.46
Mar2020 5.15 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,842.8 Cr 4.8% 5.2% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.9% 1.8% 14% Stock Analytics
DIVIS LABORATORIES ₹166,750.0 Cr 5.7% 9.6% 58.6% Stock Analytics
CIPLA ₹121,122.0 Cr -0.8% 1.2% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,487.0 Cr 0.8% 1.2% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,680.0 Cr 2.9% 6.5% 4.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.8%

5.2%

40%

SENSEX

3.6%

9.5%

13.3%


You may also like the below Video Courses